Henry Schein Strengthens Leadership Team with Executive Changes

Henry Schein Unveils New Leadership Structure to Accelerate Growth and Organizational Transformation

Henry Schein, a global provider of healthcare products, services, and technology solutions for office-based healthcare professionals, has announced a significant transformation of its executive leadership structure aimed at simplifying operations, accelerating strategic execution, and strengthening collaboration across the organization.

The company revealed that it is establishing a new Henry Schein Leadership Team (HSLT), which will replace its longstanding Executive Management Committee. Alongside the leadership restructuring, Henry Schein will also integrate its global supply chain organization with its worldwide distribution business, creating a more unified operating model designed to improve efficiency, speed decision-making, and enhance customer service.

The changes represent one of the company’s most significant organizational updates in recent years and reflect its ongoing commitment to adapting its leadership structure to meet evolving business needs while supporting long-term growth.

At the same time, Henry Schein announced that three senior executives—Executive Vice President and Chief Operating Officer Michael S. Ettinger, Executive Vice President and Chief Strategy Officer Mark E. Mlotek, and Senior Vice President of Global Supply Chain James (“Jim”) Mullins—will transition from their current executive positions later this year. While stepping down from their operational roles, all three leaders will continue supporting the company as Senior Advisors, ensuring continuity during the leadership transition.

A New Chapter in Leadership

Chief Executive Officer Fred Lowery described the organizational changes as an important milestone in Henry Schein’s evolution.

According to Lowery, the newly created Henry Schein Leadership Team has been designed to simplify the company’s management structure while enabling faster execution of strategic priorities.

The revised organization is intended to reduce complexity across the enterprise, strengthen accountability, improve collaboration among business units, and create a more agile decision-making process.

As healthcare markets continue evolving, companies are increasingly seeking organizational models that allow leaders to respond more quickly to changing customer needs, technological advancements, and competitive pressures.

Henry Schein believes the new leadership framework will better position the organization to capitalize on growth opportunities while maintaining its commitment to serving healthcare professionals around the world.

Strengthening Customer-Centric Operations

A major component of the organizational transformation involves integrating the company’s global supply chain organization with its worldwide distribution operations.

Historically, supply chain and distribution functions have operated as complementary but distinct organizations.

By bringing these teams together under a more closely aligned leadership structure, Henry Schein aims to create stronger connections between product sourcing, inventory management, logistics, and customer fulfillment.

The integration is expected to improve operational coordination while allowing the company to respond more rapidly to customer demand.

Management believes that closer alignment between supply chain planning and distribution execution will result in faster prioritization, improved efficiency, and enhanced service for healthcare providers.

This integrated approach also supports the company’s broader strategy of simplifying operations while maintaining high standards of reliability across its global distribution network.

Accelerating Decision-Making

Another objective of the new leadership structure is to enable faster and more effective decision-making.

As organizations grow in size and complexity, traditional management structures can sometimes create additional layers of review that slow execution.

The Henry Schein Leadership Team is intended to streamline communication among senior leaders while giving executives more direct oversight of corporate functions.

This approach allows decisions to move more quickly from strategic planning to implementation.

Lowery emphasized that simplifying the operating model remains an important priority as the company continues investing in innovation, customer service, and long-term growth initiatives.

By reducing organizational complexity, Henry Schein expects to become more agile in responding to changing healthcare market conditions.

Supporting Long-Term Strategic Priorities

The leadership transformation aligns with Henry Schein’s broader corporate strategy focused on sustainable growth, operational excellence, digital innovation, and customer engagement.

The company serves a wide range of office-based healthcare professionals, including dentists, physicians, veterinarians, and other healthcare providers.

Its business spans medical and dental supplies, practice management software, equipment, financial services, laboratory solutions, and technology platforms.

Managing such a diverse portfolio requires close coordination across multiple business functions.

The newly established leadership model is designed to strengthen enterprise-wide collaboration while ensuring that strategic priorities are executed consistently across all business units.

Executive Leadership Transitions

Alongside the organizational restructuring, Henry Schein announced planned leadership transitions involving three long-serving executives whose combined careers with the company span more than a century.

Michael S. Ettinger, Executive Vice President and Chief Operating Officer, Mark E. Mlotek, Executive Vice President and Chief Strategy Officer, and James (“Jim”) Mullins, Senior Vice President of Global Supply Chain, will conclude their current executive responsibilities effective October 30, 2026.

All three executives will remain in their existing positions until that date before transitioning into Senior Advisor roles.

Their continued involvement is expected to provide valuable institutional knowledge and strategic guidance as the company implements its new leadership structure.

Honoring Michael S. Ettinger’s Contributions

Michael S. Ettinger has played a central role in Henry Schein’s operational development over several decades.

Throughout his tenure, he helped establish many of the company’s corporate and operational systems while supporting global business expansion.

As Chief Operating Officer, Ettinger contributed to strengthening organizational processes, improving execution, and supporting the company’s continued international growth.

His leadership has also extended beyond day-to-day operations.

Serving as Corporate Secretary and liaison to the Board of Directors, Ettinger has worked closely with company leadership and governance teams to support effective corporate oversight.

Management credited his experience and steady leadership with helping build many of the operational capabilities that continue supporting Henry Schein’s global business today.

Recognizing Mark E. Mlotek’s Strategic Leadership

Among the executives transitioning into advisory roles, Mark E. Mlotek leaves behind one of the most significant strategic legacies in the company’s history.

During more than three decades with Henry Schein, Mlotek played an instrumental role in shaping the organization’s long-term growth strategy.

His leadership helped transform Henry Schein from a relatively small, privately owned dental mail-order business into one of the world’s leading providers of healthcare products, services, and technology solutions for office-based healthcare professionals.

Throughout his career, Mlotek was deeply involved in corporate strategy, mergers and acquisitions, partnership development, and long-term planning.

His efforts helped expand Henry Schein’s global footprint while diversifying its portfolio across dental, medical, animal health, and technology businesses.

The company also acknowledged Mlotek’s decades of service on the Board of Directors, where his strategic perspective contributed to corporate governance and long-term planning.

Celebrating Jim Mullins’ Supply Chain Leadership

James (“Jim”) Mullins has led the development of Henry Schein’s global supply chain organization for many years.

His work has been instrumental in building an efficient worldwide logistics network capable of supporting healthcare professionals across numerous countries.

Supply chain performance has become increasingly important in recent years as healthcare organizations continue addressing challenges related to inventory availability, global logistics, manufacturing disruptions, and changing customer demand.

Under Mullins’ leadership, Henry Schein strengthened its supply chain capabilities while building a highly experienced global team.

Management described the company’s supply chain organization as an important competitive advantage that supports both operational excellence and customer satisfaction.

Continuing as Senior Advisors

Although leaving their executive management positions, Ettinger, Mlotek, and Mullins will continue contributing to Henry Schein as Senior Advisors following October 30.

In these advisory roles, they will provide strategic counsel, institutional knowledge, and leadership support during the transition period.

Maintaining continuity is especially valuable during significant organizational changes, allowing new leadership structures to benefit from decades of experience while implementing new operating models.

Their continued involvement demonstrates Henry Schein’s commitment to thoughtful succession planning rather than abrupt leadership transitions.

Board Recognizes Executive Service

William K. (“Dan”) Daniel, Chairman of Henry Schein’s Board of Directors, praised the three executives for their extraordinary contributions to the company’s development.

He noted that together they represent more than 100 years of combined service to the organization.

Throughout that time, each leader played a critical role in shaping Henry Schein’s culture, operational excellence, and long-term strategic direction.

Daniel emphasized that their leadership, vision, dedication, and commitment to the company’s core values helped establish the strong foundation upon which Henry Schein continues building today.

Appreciation from the Board

Former Lead Director Philip A. Laskawy also recognized the contributions of Mark Mlotek and Michael Ettinger to the company’s Board of Directors.

Laskawy highlighted Mlotek’s three decades of Board service as well as Ettinger’s longstanding role supporting Board operations as Corporate Secretary and liaison.

According to Laskawy, both executives consistently demonstrated sound judgment, strategic insight, and unwavering commitment to the organization.

Their guidance helped strengthen corporate governance while supporting the company’s long-term success and stakeholder interests.

Commitment to Team Schein Values

In a letter distributed to employees, Lowery expressed appreciation for the three departing executives while emphasizing their lasting influence on Henry Schein’s culture.

He described Ettinger, Mlotek, and Mullins as leaders who consistently embodied the company’s Team Schein Values through their dedication, professionalism, and commitment to colleagues.

Lowery also acknowledged the personal support he received from both Ettinger and Mlotek during his own transition into the Chief Executive Officer role.

Their mentorship, guidance, and partnership helped ensure a smooth leadership transition while reinforcing the collaborative culture that has long defined Henry Schein.

The CEO thanked all three executives for their exceptional leadership and decades of service, noting that their impact extends far beyond business results.

Positioning Henry Schein for Future Growth

The leadership transformation comes at a time when the global healthcare industry continues evolving rapidly through digital transformation, changing care delivery models, and increasing customer expectations.

Healthcare providers increasingly seek integrated solutions that combine products, technology, data, and services into comprehensive practice support platforms.

Henry Schein’s new leadership structure is intended to help the company respond more effectively to these evolving market dynamics.

By simplifying operations, integrating supply chain and distribution activities, strengthening executive collaboration, and accelerating strategic decision-making, the company aims to improve organizational agility while delivering greater value to customers worldwide.

As the Henry Schein Leadership Team assumes responsibility for guiding the organization, management believes the updated operating model will support continued innovation, stronger customer relationships, operational excellence, and sustainable long-term growth.

With experienced advisors remaining actively engaged during the transition and a renewed focus on collaboration and execution, Henry Schein is positioning itself to build on its longstanding leadership in healthcare distribution and technology while preparing for the next phase of its global growth strategy.

Source link: https://news.henryschein.com/

Newsletter Updates

Enter your email address below and subscribe to our newsletter